Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria

That is the tile of my recent paper in the Journal of Medical Economics with co-authors Kyi-Sin Than, Sanjana Muthukrishnan, Jincy Paulose, Ver Bilano and Nicholas Kuypers. The abstract is below: ObjectiveParoxysmal nocturnal hemoglobinuria (PNH) is a rare and debilitating hematological disease with significant economic burden. Despite the availability of multiple therapies, there is a…

Read More

Big Bets, Long Bets: Investing in the Power of Ideas

With science funding catapulted into the cultural conversation more than ever in the last year, it faces a critical inflection point. There is an opportunity to design a path forward that builds stability in the short term and opens doors in the long term for foundational and transformational science and technology solutions that will benefit…

Read More

Journalists Draw Link Between Internet Dead Zones, Threatened Medicaid Cuts, and Health

Céline Gounder, KFF Health News’ editor-at-large for public health, discussed covid-19 vaccines and prostate cancer on WAMU’s “1A” on May 27. Click here to hear Gounder on “1A.” Senior correspondent Sarah Jane Tribble discussed how internet dead zones deepen chronic health issues in rural communities on The Commonwealth Fund’s “The Dose” on May 23. Click…

Read More

The U.S. Government and Gavi, the Vaccine Alliance

This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.

Read More

Global COVID-19 Tracker

This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additionally, the tracker reports current closure, economic, and health system policy responses to the COVID-19 pandemic globally. This tracker will be updated as new data are available.

Read More